10:17 AM EST - Sirona Biochem Corp. : Announced that the final toxicology test, a Human Repeated Insult Patch Test, has successfully been completed. Sirona is now in preparation for the increased dose (0.4%) clinical study for its skin lightening compound TFC-1067. Sirona Biochem Corp.
shares V.SBM are trading unchanged at $0.47.
